TSLA
Tesla
-- 421.060 PLTR
Palantir
-- 80.550 NVDA
NVIDIA
-- 134.700 AMD
Advanced Micro Devices
-- 119.210 OXY
Occidental Petroleum
-- 47.130 
News
$Genprex (GNPX.US)$ Genprex Receives Safety Review Committee Approval to Advance to Phase 2 Portion of Acclaim-3 Clinical Trial of Reqorsa Gene Therapy in Combination With Tecentriq in Extensive Stage Small Cell Lung Cancer
PR Newswire· 3 mins ago
Genprex Completes Phase 1 Dose Escalation Portion of Acclaim-3 Clinical Trial
Results from Phase 1 Dose Escalation Demonstrate Favorable Safety Profile of REQORSA and Tecentriq in ES-SCLC Patients
PR Newswire· 3 mins ago
Genprex Completes Phase 1 Dose Escalation Portion of Acclaim-3 Clinical Trial
Results from Phase 1 Dose Escalation Demonstrate Favorable Safety Profile of REQORSA and Tecentriq in ES-SCLC Patients
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Be a voice no echo : to 2